Skip to content

Role of NLRP6 in Chronic Periodontitis

Evaluation of Serum NLRP6 in Chronic Periodontitis Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06400069
Enrollment
50
Registered
2024-05-06
Start date
2024-12-13
Completion date
2025-11-22
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis

Keywords

NLRP6 Protein, human, Chronic Periodontitis

Brief summary

The quantification of NLRP6 in blood samples will be analyzed from individuals with chronic periodontitis but without systemic disease. Demographic and periodontal parameters will be assessed and correlated with the NLRP6 quantification using RT-PCR.

Detailed description

This study aims to collect demographic variables, including age, education level, BMI, personal habits, medication use, and history of systemic disease, from non-smoking individuals with chronic periodontitis. Initially, we will determine the expression level of the NLRP6 gene in blood samples taken from chronic periodontitis subjects who are matched for age and sex. Subsequently, we will investigate the relationship between gene expression levels, taking into account the confounding effect of body mass index, and explore how these levels correlate with the severity of the disease. In this study, two groups: chronic periodontitis (CP) and healthy controls (HC) will be examined. The CP group will consist of patients diagnosed with Stage I to IV periodontitis based on the consensus report from the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. Additionally, we will include systemically healthy individuals. Serum samples will be collected from all patients, and the Plaque Index (PI) and Gingival Index (GI) will be recorded at four sites per tooth. Furthermore, we will assess full-mouth probing depth (PD) and clinical attachment level (CAL) at six sites per tooth. The percentage of bleeding areas will be documented as the proportion of sites with bleeding on probing (BOP) within 20 seconds after probing. For blood sampling, a total of 3 mL of blood will be collected from the antecubital vein of each individual by an expert nurse from the Department of Periodontology. Statistical analysis will be conducted using statistical software for data science (Stata version 17). A significance value (p-value) of less than 0.05 will be considered statistically significant. The sample size for the study was determined using the power paired means module in Stata 17. We planned to include at least 25 individuals in each group, aiming for a significance level of 5%, statistical power of 80%, and a correlation coefficient of 0.2.

Interventions

OTHEREvaluation of serum NLRP6 levels

intervention: Evaluation of serum NLRP6 levels control: Evaluation of serum NLRP6 levels

Sponsors

Babol University of Medical Sciences
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
25 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Age: At least 25 years old * Clinical diagnosis of chronic periodontitis * At least 15 teeth in the mouth

Exclusion criteria

* premalignant lesions and cancer of the oral cavity * periodontal treatment in the last 6 months * systemic disorders affecting the periodontal condition (autoimmunity and endocrine disorders) * diabetes mellitus and rheumatoid arthritis * pregnancy or breastfeeding * taking drugs with the possibility of affecting the periodontal condition (calcium channel blockers, anticonvulsants, etc.) * Smoking * aggressive PD

Design outcomes

Primary

MeasureTime frame
Quantification of NLRP6 gen, Quantification of NLRP6 gen using RT-PCR12 months

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026